Amiodarone (tablet): Difference between revisions
Ahmed Zaghw (talk | contribs) No edit summary |
Ahmed Zaghw (talk | contribs) No edit summary |
||
| Line 38: | Line 38: | ||
|} | |} | ||
=== | ===Nexetrone injection<sup>®</sup> FDA Package Insert=== | ||
''' [[Amiodarone indications and usage|Indications and Usage]]''' | ''' [[Amiodarone indications and usage|Indications and Usage]]''' | ||
Revision as of 13:28, 13 March 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
For patient information, click here.
Synonyms / Brand Names: Cordarone, Nexetrone, Pacerone
Overview
Category
FDA Package Insert
Cordarone® tablet FDA Package Insert
Indications and Usage | Dosage and Administration | Dosage Forms and Strengths | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | Clinical Studies | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages
 |
Nexetrone injection® FDA Package Insert
Indications and Usage | Dosage and Administration | Dosage Forms and Strengths | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | Clinical Studies | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages